J B Chemicals and Pharmaceuticals P/B Ratio
J B Chemicals and Pharmaceuticals (JBCHEPHARM) P/B ratio is 9.6 (High), book value per share ₹2599.38 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. Explore JBCHEPHARM intrinsic value to estimate fundamental worth using multiple valuation models.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
JBCHEPHARM P/B Ratio — Valuation Insights & Book Value Analysis
J B Chemicals and Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 9.6 (High). For live price, earnings yield and the full fundamental profile, see JBCHEPHARM share price.
- Stock appears overvalued with PB of 9.6, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 943.5% above historical average
- Trading at premium to sector average PB of -0.01
J B Chemicals and Pharmaceuticals P/B Ratio Historical Trend
JBCHEPHARM annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read JBCHEPHARM dividend track record for the complete payout history and dividend yield track record.
JBCHEPHARM Historical P/B Ratio — Book Value Per Share & Year-End Price
J B Chemicals and Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 0.96 | ₹2599.38 | ₹2506.00 | ₹4,159 | Low |
| 2025 | 0.85 | ₹2145.62 | ₹1819.70 | ₹3,433 | Low |
| 2024 | 1.01 | ₹1826.88 | ₹1844.15 | ₹2,923 | Moderate |
| 2023 | 1.05 | ₹1550.0 | ₹1624.65 | ₹2,480 | Moderate |
| 2022 | 0.73 | ₹1336.88 | ₹972.25 | ₹2,139 | Low |
JBCHEPHARM vs Healthcare Peers — P/B Ratio Comparison
J B Chemicals and Pharmaceuticals P/B 9.6 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |